Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies. [electronic resource]
Producer: 20090326Description: 149-52 p. digitalISSN:- 1096-8652
- Adolescent
- Adult
- Aged
- Cohort Studies
- Flow Cytometry
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute -- pathology
- Middle Aged
- Myelodysplastic Syndromes -- pathology
- Neoplasm Recurrence, Local
- Neoplasm, Residual -- pathology
- Predictive Value of Tests
- Survival Analysis
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.